In the past, beginning with SECA 1, in 2008, the criteria of pre-transplant tumor diameter at > 5.5 cm and the potential for high hepatic tumor load, as well as carcinoembryonic antigen (CEA) levels before LT at >80 ug/L. The gene discussed is CEACAM5; the disease is neoplasm.